Leverage one of Canada’s most research intensive institutes to advance your business objectives.

SickKids innovators are on the front lines of health innovation. Working with IP&C, industry partners can access the research and clinical innovation ecosystem at SickKids through:

Areas of expertise

IP&C maintains a comprehensive intellectual property portfolio and has numerous research and clinical inventions available for licensing and development.

These technologies cover many areas of excellence at SickkKids and top market opportunities, including:

  • Anti-Infectives

  • Cardiovascular

  • Cystic Fibrosis

  • Developmental disorders

  • Diagnostics

  • Gene editing

  • Immunology

  • Medical devices

  • Neuromuscular disorders

  • Orphan and rare diseases

  • Paediatric oncology

  • Stem cells and regenerative medicine

Technology highlights

SickKids start-ups

IP&C helps SickKids innovators turn breakthrough research innovation into companies with real impact.

History of innovation at SickKids

From the invention of Pablum to the discovery of the cystic fibrosis gene, SickKids innovators have pushed the boundaries of medicine to help improve the lives of patients in Canada and around the globe. Be a part of innovation history at SickKids by partnering with IP&C.